key: cord-0956601-01yi70c0
authors: Kayaaslan, Bircan; Eser, Fatma; Kalem, Ayse K.; Kaya, Gamze; Kaplan, Betul; Kacar, Duygu; Hasanoglu, Imran; Coskun, Belgin; Guner, Rahmet
title: Post‐COVID syndrome: A single‐center questionnaire study on 1007 participants recovered from COVID‐19
date: 2021-07-28
journal: J Med Virol
DOI: 10.1002/jmv.27198
sha: b01d3e796a9923157ffb6444b314c115d21ba5ef
doc_id: 956601
cord_uid: 01yi70c0

Post recovery manifestations have become another concern in patients who have recovered from coronavirus disease 2019 (COVID‐19). Numerous reports have shown that COVID‐19 has a variety of long‐term effects on almost all systems including respiratory, cardiovascular, gastrointestinal, neurological, psychiatric, and dermatological systems. We aimed to investigate the prevalence and characteristics of the post‐COVID syndrome among COVID‐19 survivors and to determine the factors associated with persistent symptoms. This prospective study enrolled in patients with COVID‐19 followed in hospital or outpatient clinics in Ankara City Hospital. We performed a special questionnaire to inquire about the presence of persistent symptoms beyond 12 weeks from the first diagnosis. Demographic data, comorbid diseases, characteristics of acute COVID‐19, presence of persistent symptoms by systems, and knowledge about outpatient clinic visits after recovery were assessed. Of a total of 1007 participants, 39.0% had at least one comorbidity, and 47.5% had persistent symptoms. Fatigue/easy fatigability, myalgia, and loss of weight were the most frequent persistent symptoms (overall 29.3%) followed by respiratory symptoms (25.4%). A total of 235 participants had visited outpatient clinics due to several reasons during the post‐COVID‐19 period, and 17 of them were hospitalized. Severe acute COVID‐19, hospitalization, and presence of comorbidity were independent factors for the development of persistent symptoms. Fully understanding the spectrum of the post‐COVID syndrome is essential for appropriate management of all its long‐term effects. Our study once again underlined the fact that the prevalence of post‐COVID syndrome is higher than expected and concerns many systems, and a multidisciplinary follow‐up should be provided to COVID‐19 survivors in the post recovery period.

Coronavirus disease 2019 (COVID-19) has been one of the major pandemics affecting all the world and human beings since the end of 2019. Although the severe course of the disease has caused concern since the beginning of the pandemic, as time has passed, the appearance of many post recovery manifestations on survivors has become another cause for concern. Numerous reports from various parts of the world have shown that COVID-19 has a variety of longterm effects on almost all systems including respiratory, cardiovascular, gastrointestinal, neurological, psychiatric, and dermatological systems. 1 A considerable part of patients, up to 87.5%, recovering from acute infection continue to suffer from a variety of symptoms including dyspnea, cough, myalgia, fatigue, and headache. [2] [3] [4] The data that people who have mild illness or no symptoms during acute infection also suffer from long-term symptoms exhibit that the disease causes greater damage than appears in infected persons.

The nomenclature about ongoing symptoms after recovery and the determination of their periods differs in studies and institutions' definitions such as the Centers for Disease Control and Prevention (CDC) and The National Institute for Health and Care Excellence (NICE). 1,5-7 Greenhalgh et al. 5 defined ongoing symptoms beyond 3 weeks from the disease onset as post-acute COVID-19 and beyond 12 weeks as chronic COVID-19. 7 CDC proposed dividing the disease into three periods such as acute COVID-19 (the first 2 weeks from symptom onset), post-acute hyperinflammatory illness (between 2 and 4 weeks from symptoms onset), and late sequelae period (more than 4 weeks from symptom onset) based on the population-based framework. 5 The NICE guideline recommends using the term long-COVID for signs and symptoms that continue for more than 4 weeks and are not explained by an alternative diagnosis, and the term post-COVID syndrome for ongoing signs and symptoms beyond 12 weeks after infection. 6 Here, we presented a single-center questionnaire study assessing the prevalence, variety, and severity of persistent symptoms in the post-COVID period and investigating the post recovery follow-up, outpatients clinic visits, and hospital re-admissions.

We preferred to use post-COVID syndrome for the ongoing symptoms and signs of more than 12 weeks.

This prospective study was conducted in patients with COVID-19 who were hospitalized in COVID-19 wards or followed in outpatient clinics in Ankara City Hospital, between August 1, 2020, and October 31, 2020. The ethical approval was obtained from Ankara City Hospital Ethical Committee 1.

In late May 2020, the hospital administration established post-COVID outpatient clinics for COVID-19 individuals discharged from the hospital after recovering from the disease and those who recovered without the need for hospitalization. The diagnosis of COVID-19 was based on a positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction on a nasopharyngeal sample and/or typical pulmonary involvement on computed tomography. COVID-19 survivors who met World Health Organization (WHO) criteria for discontinuation of isolation (for symptomatic patients; 10 days after symptom onset, plus at least three additional days without symptoms, and for asymptomatic cases; 10 days after a positive test for SARS-CoV-2 without requiring retesting) were followed up in these clinics. 8 We designed a special questionnaire to inquire about the current health status of patients and their persistent symptoms in the post-COVID period and contacted all eligible patients. As this survey aimed to investigate the prevalence of post-COVID syndrome, participants who have had COVID-19 at least 3 months before were included in the survey. The questionnaires were filled out by trained three independent physicians face-to-face or by telephone between December 2020 and February 2021. Face-to-face questionnaires were performed in our COVID-19 outpatient clinics. At the beginning of the questionnaire, the respondents were asked if they accept to participate in the study, and after verbal consent, the questions in the survey were directed to the participants. After the patient records were completed, the data were checked by a study member, other than those who performed the questionnaire.

The information included in the questionnaire were age, sex, comorbid diseases, characteristics of acute COVID-19, history of hospitalization (disease severity, length of hospital stay, need for respiratory supports, and need for intensive care unit [ICU]), duration since symptoms onset, presence of persistent symptoms by systems, and knowledge about outpatient clinic visits after recovery. Data about acute COVID-19 were obtained from respondents' own selves and the hospital automation system. Acute COVID-19 disease severity of patients was recorded as mild to moderate, severe, and critical illness based on WHO COVID-19 technical guidelines. 9 The duration of disease was calculated from the first COVID-19 diagnosis and it was taken into consideration that a period of at least 3 months after recovery should be passed to avoid confusion regarding terminology. The symptoms of patients were grouped by the systems as follows: general (fatigue or easy fatigability, myalgia, and loss of weight), respiratory (dyspnea, chest pain, cough, and wheezing), cardiovascular (palpitation), neuropsychiatric (headache, insomnia, hypersomnia, nightmare, concentration or memory deficit, and mood changes as depression and anxiety), dermatologic (hair loss and rash), gastrointestinal (abdominal pain, diarrhea, and constipation), and genitourinary systems (uncontrolled bladder). To evaluate the level of being affected by the symptoms, participants were asked to score each symptom from 0 (have no problem) to 10 (have extreme). We used a scale to investigate the out-of-hospital situation of the participants based on a scale of COVID-19 Yorkshire Rehabilitation Screening (C19-YRS) Tool and applied it to each symptom. 10 Outpatient clinics where the patients visited, whether there was a need for medical assistance or a need for rehospitalization were questioned. Information was asked about the reasons for medical assistance and reasons for rehospitalization and the clinics where the patients were hospitalized. The number of days patients are away from work and the current daily activity performance status of the patients were evaluated.

All analyses were performed using IBM SPSS V.21 software version.

Descriptive statistics were presented as mean ± standard deviation (SD) or medians plus with quartiles (interquartile range [IQR] 25th-75th percentile) for continuous variables that do not have a normal distribution and as frequency and percentages for categorical variables. Student t-test was used in the comparison of continuous variables for normally distributed data, and Mann-Whitney U test for non-normal distribution.

The χ 2 test was used for comparing categorical variables in parametric conditions. A p value of less than 0.05 was considered statistically significant. Multivariate logistic regression was used to determine independent predictors for persistent symptoms beyond 12 weeks after recovery. Table 1 . (Table 3) .

Most outpatient admissions were made to infectious diseases (22.8%), cardiology (14.3%), and internal medicine (13.1%). The distribution of outpatient clinic visits after recovery is shown in Figure 2 .

In multivariate analysis, having a severe acute illness, hospitalization, and presence of comorbidity were detected as independent factors for the development of persistent symptoms (Table 4 ).

In the present study, we assessed the prevalence and characteristics 

In our study, 47.5% of the participant reported suffering from one or more persistent symptoms at the time of the questionnaire.

Previous studies have reported persistent symptoms in a wide range varying from 13.3% to 96.0%, but most of them reported high rates. 3, 4, [11] [12] [13] [14] [15] [16] [17] [18] The diversity in study results can be explained with the differences in several factors: the characteristics of the study population (e.g., inpatients/outpatients, differences in disease severity of patients enrolled in the study), study designs (e.g., active questioning, analyzing of outpatient clinic and readmission records, one-third of patients were re-hospitalized, and more than one-tenth died during an average follow-up period of 140 days. 18 However, all three studies were done only in hospitalized patients. Therefore, relatively severe patients are likely to be included in studies. Here, we included patients who were followed up both outpatients and inpatients in all severity levels of the disease, from mild to critical illness. Therefore, the study population represents almost the entire COVID-19 population.

COVID-19 is a multisystem disease with a wide range of long-term effects on almost all systems. Therefore, clinical multidisciplinary evaluation should be done to manage long-term persistent symptoms and to minimize post-COVID ongoing harmful effects. In our study, more than half of the patients having persistent symptoms had three or more symptoms. The previous two studies reported three or more persistent symptoms in 55.2% and 19.7% of the patients. 3, 14 Systemic symptoms were the most common complaints, and 24.3% of the patients reported suffering from fatigue/easy fatigability. Several other studies also reported fatigue as the most common symptom. 3, 4, 11, 12, 14, 16 COVID-19 can lead to pulmonary complications such as fibrosis, We used a scale to investigate the out-of-hospital situation of the participants with a scale based on the C19-YRS tool. C19-YRS tool is a telephone screening tool and has been developed by multidisciplinary-rehabilitation teams to assess the patients in terms of their ongoing symptoms of COVID-19 and to provide guidance for the required rehabilitations. 10 The patients with persistent symptoms reported their symptoms relatively at a mild-to-moderate level at the time of the questionnaire. The C19-YRS toll aims to provide an intervention guide to provide needed support in the community. Thus, the individuals may be easily directed to the relevant clinics or rehabilitation centers.

The persistent symptoms may be associated with different reasons in- 

In the present study, although most participants had a mild-moderate COVID-19, persistent symptoms were common even among them.

Hospital admission for acute COVID-19, severe COVID-19, and presence of comorbidity were independent predictors for the development of symptom persistence. Previous studies reported a relationship between disease severity, hospital admission, and COVID-19 manifestations which is similar results to our finding. 4, 6, 14 In contrast to our results, two other previous studies did not find an association between comorbidity and post-COVID syndrome. 14,17 More than three comorbidities were reported as a predictor for a delayed return to usual health status in another study. 12 The severity of acute disease and the requirement of hospital admission appear to be the main predictors for post-COVID syndrome. As severe COVID-19 usually required prolonged hospitalization and therefore, patients had to struggle with several problems such as the development of a complication, physiological changes, and deconditioning, this is an expected result. 12, 23 There are many strengths of our study. First, to our knowledge, this study, investigating the post-COVID syndrome through a one-toone questionnaire, has the highest number of participants with more than one thousand. Second, the study included an adequate number of patients from each of the disease severity categories, including mild-moderate, severe, and critical illness, like its real prevalence among the community. Therefore, it represents well the population of COVID-19. Thirdly, we investigated features of admission to outpatient clinics such as its prevalence and reasons and the rates of hospitalization, and medical assistance. Fourth, we used a scale from 0 to 10 to evaluate the levels of being affected by symptoms.

This study has some limitations. This study is based on the patient's self-declaration. There may be differences in perceiving and expressing or taking seriously patients' symptoms. And the retrospective character of our study may cause some information not to be remembered. In addition, the study was conducted in a large but single center.

Our results showed that a considerable part of patients with COVID-19 had persistent symptoms even 4-5 months after COVID-19 diagnosis, and even patients with a mild-to-moderate disease suffered from persistent symptoms. Some patients visited the outpatient clinics particularly for respiratory or cardiovascular symptoms, however, patients with neuropsychiatric symptoms ignored their symptoms possibly due to low awareness of symptoms.

Although infections and requires detailed monitoring, even after recovery. In the post-COVID period, health care should be planned as multidisciplinary care to address the patient as a whole.

Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-haulers

NICE guideline on long COVID

Persistent symptoms in patients after acute COVID-19

Assessment and characterisation of post-COVID-19 manifestations

Management of post-acute COVID-19 in primary care

A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications

Defining post-COVID symptoms (postacute COVID, long COVID, persistent post-COVID): an integrative classification

World Health Organization. Interim Guidance on Ending Isolation and Precautions for Adults with COVID-19

World Health Organization

Assessing long-term rehabilitation needs in COVID-19 survivors using a telephone screening tool (C19-YRS tool)

Post-COVID-19 syndrome among symptomatic COVID-19 patients: a prospective cohort study in a tertiary care center of Bangladesh

Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network -United States

Follow-up of adults with noncritical COVID-19 two months after symptom onset

Long COVID': persistent COVID-19 symptoms in survivors managed in Lagos State

Attributes and predictors of long COVID

Persistent symptoms in patients recovering from COVID-19 in Denmark

Post-acute COVID-19 syndrome. Incidence and risk factors: a mediterranean cohort study

Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress disorder, and psychological distress among populations affected by the COVID-19 pandemic: a systematic review and meta-analysis

Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors

Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA

Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19

Long COVID: an overview

Post-COVID syndrome: A single-center questionnaire study on 1007 participants recovered from COVID-19

The authors declare that there are no conflicts of interest. 

https://orcid.org/0000-0001-6692-3893